Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 Last updated on 19 January 2023
Reviewed Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 Last updated on 16 January 2023
Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 Last updated on 16 January 2023
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
regard, the company would like to report operating results for the second quarter of 2020 as follows Consolidated Financial Statements Ekachai Medical Care Public Company Limited and its subsidiaries
According to the resolution of the meeting of the Board of Directors No. 6/2017 of Rajthanee Hospital Public Company Limited (the “Company”) held on 10 November 2017, approving the reviewed consolidated
auditor as follows: Statements of Comprehensive Income for the 2nd Quarter Ended June 30, 2020 Operation : Consolidated Profit & Loss Statement 2Q 2Q % Unit : THB million 2020 2019 change Revenue from Non
affected by the spread of COVID-19 as follows: Revenue Unit: Million Baht Q1/19 Q4/19 Q1/20 Consolidated Statement Revenue 194.29 222.62 167.85 Profit(loss) from exchange rate 0.54 0.35 0.20 Other Revenue